Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRR25 Inhibitors

PRR25 inhibitors are a class of compounds that selectively target and inhibit the activity of the proline-rich protein 25 (PRR25). This protein belongs to the larger family of proline-rich proteins, which are characterized by their high content of proline residues. PRR25 is a protein that plays a role in various cellular processes, particularly those involving signal transduction and protein-protein interactions. Due to its structure, PRR25 is involved in mediating interactions between proteins through its proline-rich domains, which are recognized by SH3 (Src Homology 3) domains and other proline-binding motifs present in many signaling molecules. The inhibition of PRR25 affects these protein interactions and can modulate various intracellular signaling pathways that depend on these interactions.

The development of PRR25 inhibitors often involves screening for molecules that can specifically bind to the proline-rich regions of the PRR25 protein, thereby blocking its ability to engage with its interacting partners. Structurally, many PRR25 inhibitors mimic the proline-rich motifs or adopt conformations that can compete for binding with SH3 or other domains, effectively disrupting the natural interaction network of PRR25 within the cell. This disruption can have downstream effects on the signaling cascades and pathways that PRR25 is a part of, leading to alterations in cellular function. These inhibitors are often designed using insights from the protein's three-dimensional structure and the dynamics of its interaction with other cellular proteins. As a result, the structural complexity and specificity of PRR25 inhibitors reflect the intricate role that PRR25 plays in cellular signaling mechanisms.

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 169316

152121-53-4sc-204168
sc-204168A
sc-204168B
sc-204168C
1 mg
5 mg
10 mg
25 mg
$86.00
$153.00
$275.00
$452.00
3
(1)

A p38 MAPK inhibitor which may modulate the activity of PRR25 if it is part of stress response signaling.